ABOUT US

The Zhongguancun Shuimu Medical Technology Service Group was established in 2017 and is headquartered in the Beijing Yizhuang Economic and Technological Development Zone. It is committed to accelerating the process of registration and listing of innovative medical device products, and solving the "last mile" problem of industrialization for innovative medical device companies. The Group is the chairman unit of the Clinical Trial Branch of the China Association for Medical Devices Industry, the executive vice chairman unit of the Application Evaluation Branch of the China Medical Equipment Association, and the chairman unit of the Medical Device Committee of the Beijing Pharmaceutical Association.

Company Introduction
Development History
Company Honors
Subsidiary
Team Introduction
Corporate News
Shumuk University
  • 01

    Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.

    Inspection and Testing Service Platform

    Beijing Zhongguancun Shumu Medical Technology Co., Ltd. is the first privately-owned third-party professional medical device inspection and testing organization established independently in China. It has obtained the China Metrology Accreditation (CMA) and the China National Accreditation Service for Conformity Assessment (CNAS) certification.
  • 02

    Chengdu Shuimu Medical Technology Co., Ltd.

    Medical Device Design and Evaluation Platform

    Chengdu Shuimu Medical Technology Co., Ltd. has established a joint laboratory called "Shuimu Medical - University of Electronic Science and Technology of China" in close collaboration with the University of Electronic Science and Technology of China. The laboratory is dedicated to assisting medical device companies in their product development through research and development support.
  • 03

    Beijing Shuimu Jingchuang Pharmaceutical Technology Co., Ltd.

    Clinical CRO Platform

    Beijing Shuimu Jingchuang Pharmaceutical Technology Co., Ltd. is a Contract Research Organization (CRO) specializing in providing professional clinical research technical services for medical device companies. We primarily offer specialized technical services and one-stop solutions for medical device clinical trials, medical writing, global registration, GMP consulting, and other related services.
  • 04

    Beijing Shuimu JiHeng Biotechnology Co., Ltd

    IVD standard and quality control product research and production platform

    Beijing Shuimu JiHeng Biotechnology Co., Ltd. is a comprehensive service provider of domestically developed standard products in all categories. Its research and development laboratory covers an area of 1000m², and its GMP production workshop covers an area of 1300m².
  • 05

    Beijing Shuimu Jinyi Medical Technology Services Co., Ltd.

    Medical device CDMO platform

    The Zhongguancun Shuimu Medical CDMO platform is independently managed and operated by Beijing Shuimu Jinyi Medical Technology Services Co., Ltd. It combines the CRO (Clinical Research Outsourcing) and CDMO (Medical Device Manufacturing Outsourcing) service models to provide customers with a one-stop medical device CDMO service
  • 06

    Beijing Shuimu Lingrui Medical Technology Co., Ltd

    Digital Operations Platform for the Life Sciences Industry

    Beijing Shuimu Lingrui Medical Technology Co., Ltd. is located in Beijing Economic-Technological Development Area (BDA), and is a subsidiary of Zhongguancun Shuimu Medical Technology Service Group

Zhongguancun Shumuk International Innovation Center

The Zhongguancun Shuimu International Innovation Center was established in 2023. It can provide research and development, production, and operation facilities for startups, operating enterprises, research institutes, and medical/hospital institutions, as well as shared facilities in communication, network, and office areas. It also provides systematic training and consultation, as well as support in policies, financing, laws, and market promotion, to reduce the entrepreneurial risks and costs of startups, improve their survival and success rates, Efficiently achieve the transformation from innovative concepts to productization.